News tagged with relenza
Continuing uncertainties surround anti-influenza drug
Incomplete availability of data has hampered a thorough assessment of the evidence for using the anti-influenza drug oseltamivir, a Cochrane Review has found. However, after piecing together information from over 16,000 pages ...
Medicine & Health / Medications
Jan 18, 2012 |
not rated yet |
0
Flu: Drugs stockpile an option for rich countries, not poor
Stockpiling antiviral drugs as a weapon against pandemic flu saves lives but, when measured as a tool for averting economic damage, is an option only open to rich countries, a study published on Wednesday said.
Feb 02, 2011 |
not rated yet |
0
Tamiflu is more effective at relieving flu symptoms than a combination of tamiflu and relenza: study
In adults with seasonal influenza A virus infection, the combination of the drugs oseltamivir (tamiflu) and zanamivir (relenza) is less effective than oseltamivir monotherapy and not significantly more effective than zanamivir ...
Medicine & Health / Medications
Nov 02, 2010 |
not rated yet |
0
Expert panel to view confidential swine flu papers
(AP) -- An expert panel investigating the World Health Organization's response to last year's swine flu outbreak said Wednesday it wants to see confidential exchanges between the U.N. body and drug companies.
May 19, 2010 |
not rated yet |
0
Study finds that drugs used for treatment of influenza in pregnancy appear to be safe
Tamiflu and two other drugs used to treat influenza appear safe for pregnant women and their babies, researchers at UT Southwestern Medical Center have found in a retrospective study of 239 cases of women who received the ...
Medicine & Health / Medications
Apr 27, 2010 |
not rated yet |
0
Rapid development of drug-resistant 2009 H1N1 influenza reported in 2 cases
Two people with compromised immune systems who became ill with 2009 H1N1 influenza developed drug-resistant strains of virus after less than two weeks on therapy, report doctors from the National Institute of Allergy and ...
Mar 26, 2010 |
not rated yet |
1
|
Netherlands reports mutant swine flu death
Dutch authorities said Thursday a patient infected by a mutant strain of the swine flu virus had died, but added that this was not the cause of death.
Dec 03, 2009 |
not rated yet |
0
Swine flu vaccine effective despite mutations: experts
Swine flu vaccines are still effective despite reported cases of mutations in the A(H1N1) virus, health experts in Europe and North America said Saturday.
Nov 21, 2009 |
1 / 5 (1) |
1
FDA warns: Swine flu scams lurk on the Internet
(AP) -- Air "sterilizers." A photon machine. Supplement pills to boost the immune system. Protective shampoos and face masks. Even fake Tamiflu.
Medicine & Health / Medications
Oct 22, 2009 |
not rated yet |
1
Drugmaker reports shortage of kids' Tamiflu
(AP) -- The maker of Tamiflu on Wednesday said there's a shortage of the children's version of the drug - the first-line treatment for swine flu and seasonal flu.
Medicine & Health / Medications
Sep 23, 2009 |
not rated yet |
0
Did drug-resistant swine flu spread at NC camp?
(AP) -- Health officials are reporting what may be the first instance of a Tamiflu-resistant swine flu virus spreading from one person to another.
Sep 10, 2009 |
not rated yet |
0
US says Tamiflu for the sick, not a preventive
(AP) -- Federal health officials put out new guidelines Tuesday that say the flu medicines Tamiflu and Relenza should only be used to treat people who are sick with the flu and at high risk for complications.
Medicine & Health / Medications
Sep 08, 2009 |
not rated yet |
0
Study: New treatment may combat drug-resistant flu
(AP) -- A new and unlicensed treatment for swine flu could be used in patients who have Tamiflu-resistant viruses, doctors say. In an article published Friday in the medical journal Lancet, British doctors describe how they ...
Sep 03, 2009 |
5 / 5 (1) |
0
Antivirals 'little or no effect' on flu complications in children
(PhysOrg.com) -- The antivirals oseltamivir (Tamiflu) and zanamivir (Relenza) are unlikely to prevent complications in children who have swine flu, according to research published by the BMJ today.
Aug 10, 2009 |
not rated yet |
0
Researchers tackle influenza by studying human behavior
Researchers from The University of Texas at Austin will participate in a $3 million, five-year grant from the National Institutes of Health (NIH) to fight influenza and other diseases by creating models that simulate the ...
Aug 04, 2009 |
not rated yet |
0
Zanamivir
Zanamivir (INN) (pronounced /zəˈnæmɨvɪr/) is a neuraminidase inhibitor used in the treatment and prophylaxis of Influenzavirus A and Influenzavirus B. Zanamivir was the first neuraminidase inhibitor commercially developed. It is currently marketed by GlaxoSmithKline under the trade name Relenza.
For more information about Zanamivir, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
